Yettwaleqqem
WHO updated recommendations on HIV clinical management: recommendations for a public health approach
World Health Organization
Tuḍḍiwin n tɣawsiwin 2025TAFFA N TMUSNIWIN TUSNANIN
Ilugan n usḍibbi
Af-d ilugan unṣiben, arraten n umtawa d yileqman i d-ssufɣen yimusnawen d tedbirtin n ṣṣeḥḥa.
Iɣbula unṣiben, yettwamanenTuddsiwin tusnawin d tedbirtin n ṣṣeḥḥa
Isallen yettwaleqqmenAsenqed ussnan ameɣlal
Anekcum s war azal i yimseɣtayenI ɣur n temɣiwent n yimdanen n tẓṛi
Tisuffaɣ d ileqman ixataren
Wali isuffeɣen ineggura
Yettwaleqqem
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
European Society of Cardiology
Tasleḍt n wul 2025
Asuffeɣ unṣib
Evidence-informed diagnosis of cerebral palsy in community settings
Canadian Paediatric Society
Taseḍṛit n warrac 2026Akk yilugan (126 igmuḍ)
Imsizzel
Archived 16: Recommendations on the use of COVID-19 vaccines [2021-07-22]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2021) on “Archived 16: Recommendations on the use of COVID-19 vaccines [2021-07-22]”. Archived version of the recomme...
Archived 17: Recommendations on the use of COVID-19 vaccines [2021-09-28]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2021) on “Archived 17: Recommendations on the use of COVID-19 vaccines [2021-09-28]”. Archived version of the recomme...
Archive 18: Recommendation on the use of mRNA COVID-19 vaccines in adolescents 12 to 17 years of age [2021-08-27]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2021) on “Archive 18: Recommendation on the use of mRNA COVID-19 vaccines in adolescents 12 to 17 years of age [2021-...
Archived 21: Summary of National Advisory Committee on Immunization statement: Interim guidance on booster COVID-19 vaccine doses in Canada
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2021) on “Archived 21: Summary of National Advisory Committee on Immunization statement: Interim guidance on booster...
Archived 21: National Advisory Committee on Immunization statement: Interim guidance on booster COVID-19 vaccine doses in Canada [2021-10-29]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2021) on “Archived 21: National Advisory Committee on Immunization statement: Interim guidance on booster COVID-19 va...
Archive 22: Recommendations on the use of COVID-19 vaccines [2021-10-22]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2021) on “Archive 22: Recommendations on the use of COVID-19 vaccines [2021-10-22]”. Recommendations on the use of au...
Archived 23: Table of updates: Recommendations on the use of COVID-19 vaccines [2020-12-12 to 2021-10-22]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2021) on “Archived 23: Table of updates: Recommendations on the use of COVID-19 vaccines [2020-12-12 to 2021-10-22]”....
Archived 24: Summary of National Advisory Committee on Immunization (NACI) statement: Recommendation on the use of the Pfizer-BioNTech COVID-19 vaccine (10 mcg) in children 5 to 11 years of age [2021-11-19]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2021) on “Archived 24: Summary of National Advisory Committee on Immunization (NACI) statement: Recommendation on the...
Archived 24: National Advisory Committee on Immunization (NACI) statement: Recommendation on the use of the Pfizer-BioNTech COVID-19 vaccine (10 mcg) in children 5 to 11 years of age [2021-11-19]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2021) on “Archived 24: National Advisory Committee on Immunization (NACI) statement: Recommendation on the use of the...
Archived 25: NACI rapid response: Updated recommendation on the use of authorized COVID-19 vaccines in individuals aged 12 years and older in the context of myocarditis and pericarditis reported following mRNA COVID-19 vaccines [2021-12-03]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2021) on “Archived 25: NACI rapid response: Updated recommendation on the use of authorized COVID-19 vaccines in indi...